Figure 3 | Translational Psychiatry

Figure 3

From: The early growth response protein 1-miR-30a-5p-neurogenic differentiation factor 1 axis as a novel biomarker for schizophrenia diagnosis and treatment monitoring

Figure 3

Response of the EGR1-miR-30a-5p-NEUROD1 axis to antipsychotics treatment. The early growth response protein 1 (EGR1) messenger RNA (mRNA) level was slightly increased after the treatment, which was not statistically significant. However, the treatment resulted in a significant elevation of miR-30a-5p levels and a significant reduction of neurogenic differentiation factor 1 (NEUROD1) mRNA levels, respectively. *P<0.05; **P<0.01.

Back to article page